$17.06
+0.06%
N/A+$0.01
Healthcare
Biotechnology
NASDAQ
활발히 거래 중
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the advancement and commercialization of Haduvio, a potential treatment for debilitating neurologically ...
